Severe idiosyncratic drug reaction (Lyells syndrome) after ingesting dihydroartemisinin

Nigerian Journal of Clinical Practice

Volumn 12, Issue 2, 2009, Pages 224-227

  Ugburo, A O ^a   Ilombu, C A ^a   Temiye, E O ^a   Fadeyibi, I O ^a   Akinolai, O I ^b  

^a LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^b LAGOS STATE UNIVERSITY   (Nigeria)

Author keywords

Artemisinine; Lyells syndrome; Toxic epidermal necrolysis

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROQUINGHAOSU;

ADULT; ARTICLE; CASE REPORT; CHILD; FEMALE; HUMAN; MALE; TOXIC EPIDERMAL NECROLYSIS;

ADULT; ANTIMALARIALS; ARTEMISININS; CHILD; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; MALE;

EID: 70349934824     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Wolff R., Orion E. Life threatening acute adverse eoetaneous drug reaction. Clinics in dermatology. 2005;23(2):171-181.
2. Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br. J. Dermatology 1956;68(11):355-361.
3. Cabral L, Riobom F, Diogo C. Toxic epidermal necrolysis. Annals of burns and fire disaster. 2004;17(2):90-102.
4. Roujeau JC, Guillaume JC, Fabre JP, Penso D. Toxic epidermal necrolysis: Incidence and drug aetiology in France. Arch. Dermatolol. 1990;126(1):37-43.
5. Brambilla G Brucato F, Angrisano A, Palmieri G Treatment of Toxic epidermal necrolysis. Annals of burns and fire disaster 2002;15(1):17-21.
6. Stern RS. Improving outcome of patient with Toxic epidermal necrolysis and StevensJohnson's syndrome. Arch. Dermatology. 2000;136(3):410-411.
7. Acikel C, Erne F, Ergo O, Calicos B. Topical treatment of toxic epidermal necrolysis using Midterm and glycerol-preserved human cadaver skin. Annals of burns and fire disaster. 2002; 15(2).
8. World Health Organization. WHO guidelines for treatment of malaria. World Health Organization, Geneva; WHO/HTM/MAL/2006.1108 acessed 11/6/07.
9. FMOH. Federal Republic of Nigeria National antimalarial treatment policy. Abuja: Federal Ministry of Health; 2005.